REVIEW AND EVALUATION OF DRUG ABUSE DATA FLEXERILTM MR

8/10/99


Click here to start


Table of Contents

REVIEW AND EVALUATION OF DRUG ABUSE DATA FLEXERILTM MR

PPT Slide

DAWN

DAWN (cont.)

DAWN - ED Mention

Frequency of ED Mentions (DAWN)a Relative to Total Prescriptions (1992-1997)

ED Mentions (DAWN) 1977-1982

DAWN - ED Mentions for Taking Cyclobenzaprine (1992-1997)

DAWN - ED Mentions for Taking Cyclobenzaprine (1992-1997)

DAWN ED Mentions for Taking Cyclobenzaprine (1995-1997)

Medical Examiner Reports (1992-1997)

AAPCC Data Related to Drug Abuse/Misuse

Conclusions From AAPCC (Poison Control Center Data)

Conclusions From AAPCC (Poison Control Center Data)

Conclusions From AAPCC (Poison Control Center Data)

Conclusions From AAPCC (Poison Control Center Data)

Conclusions From AAPCC (Poison Control Center Data)

Conclusions From AAPCC (Poison Control Center Data)

AERS

Conclusions

Author: KLEINM